Delivery Order SPE2DB22D1106-SPE2DB25FEZD7
Award Date 7/22/25
Potential Completion Date 8/12/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Bosulif 400 mg tablets (30-count packages) valued at $11,815.63. The contract is not set-aside and represents a competitively awarded order with an ultimate completion date of October 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $11,815.63 and completion deadline of August 29, 2025. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major...
- AmerisourceBergen Drug Corp was awarded a competitively bid delivery order valued at $23,631.26 for BOSULIF 400 mg tablets (30-count packages) by the Defense Logistics Agency Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,815.63 to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 30, 2025. The award was issued on June 6, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Bosulif is a targeted cancer therapy medication, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a contract ceiling value of $11,408.90. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a ceiling value of $11.4K. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,704.45 on July 2, 2025, for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price, competitively awarded contract, which is non-set-aside, will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a $23,631.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units) under a non-competitive, non-set-aside procurement. The order, issued on September 9, 2025, with completion targeted for September 30, 2025, represents a single delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of BOSULIF 400 mg tablets (30-count packages) with a ceiling value of $23,631.26. The contract is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- AmerisourceBergen Drug Corp received a firm fixed price delivery order valued at $5,704.45 from the Defense Logistics Agency (DLA) for 120 tablets of Bosulif 100 mg, a targeted cancer therapy medication. Awarded on September 17, 2025, with an ultimate completion date of October 8, 2025, this non-set-aside contract represents a competitive award to support federal medical procurement needs. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...